Evidence map›Paper›PMID 38467649›Full record

ArticleNature communications2024

YTHDF2 governs muscle size through a targeted modulation of proteostasis.

Christopher J Gilbert, Charles P Rabolli, Volha A Golubeva, Kristina M Sattler, Meifang Wang, Arsh Ketabforoush, W David Arnold, Christoph Lepper, Federica Accornero

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. The role of mNaunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  3. Review
  4. YTHDC1-Mediated mJournal of agricultural and food chemistry · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Christopher J GilbertDepartment of Physiology and Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, USA.
Charles P RabolliDepartment of Physiology and Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, USA.
Volha A GolubevaDepartment of Physiology and Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, USA.
Kristina M SattlerDepartment of Physiology and Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, USA.ORCID 0000-0002-3603-8516
Meifang WangNextGen Precision Health, University of Missouri, Columbia, MO, USA.
Arsh KetabforoushNextGen Precision Health, University of Missouri, Columbia, MO, USA.ORCID 0000-0002-2773-3170
W David ArnoldNextGen Precision Health, University of Missouri, Columbia, MO, USA.
Christoph LepperDepartment of Physiology and Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, USA.
Federica AccorneroDepartment of Physiology and Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, USA. federica_accornero@brown.edu.ORCID 0000-0003-1209-7228

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
Post-transcriptional regulation of cardiac hypertrophyR01HL136951 · NHLBI · OHIO STATE UNIVERSITY · PI Federica Accornero · 2017 to 2026
$4.7M
Mechanistic characterization of a new master regulator of cardiac virus infectionsR01HL154001 · NHLBI · OHIO STATE UNIVERSITY · PI ACCORNERO, FEDERICA, YOUNT, JACOB · 2020 to 2023
$2.3M
Regulation of Muscle Stem Cell Number via Paracrine SignalingR01AR078231 · NIAMS · OHIO STATE UNIVERSITY · PI LEPPER, CHRISTOPH · 2021 to 2025
$1.9M
Structured Illumination Microscope for high resolution imaging of cells and tissuesS10OD025008 · OD · OHIO STATE UNIVERSITY · PI STOODLEY, PAUL · 2019 to 2019
$593k
The Role of m6A Binding Protein YTHDF1 in Cardiac HomeostasisF30HL160104 · NHLBI · OHIO STATE UNIVERSITY · PI GOLUBEVA, VOLHA · 2021 to 2024
$160k
YTHDF3 as a critical regulator of cardiac functionF30HL165812 · NHLBI · OHIO STATE UNIVERSITY · PI RABOLLI, CHARLES P. · 2023 to 2025
$142k
The role of YTHDF2 in postnatal cardiac growth and homeostasisF31HL158234 · NHLBI · OHIO STATE UNIVERSITY · PI GILBERT, CHRISTOPHER J. · 2021 to 2022
$83k
NCI NIH HHS P30 CA016058NHLBI NIH HHS F30 HL160104NHLBI NIH HHS F30 HL165812NHLBI NIH HHS F31 HL158234NHLBI NIH HHS R01 HL136951NHLBI NIH HHS R01 HL154001NIAMS NIH HHS R01 AR078231NIH HHS S10 OD025008
6 · The paper itself

Abstract

The regulation of proteostasis is fundamental for maintenance of muscle mass and function. Activation of the TGF-β pathway drives wasting and premature aging by favoring the proteasomal degradation of structural muscle proteins. Yet, how this critical post-translational mechanism is kept in check to preserve muscle health remains unclear. Here, we reveal the molecular link between the post-transcriptional regulation of m

Indexed as

ProteostasisTranscription FactorsGene Expression RegulationMusclesSmad3 ProteinTransforming Growth Factor betaSmad3 ProteinTranscription FactorsTransforming Growth Factor beta

Identifiers

PMID38467649
PMCPMC10928198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.